Fig. 6From: Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II studyCumulative incidence of physician-reported late GI (A) and GU (B) toxicity grade 2 or worse according to the RTOG scaleBack to article page